26 related articles for article (PubMed ID: 38572811)
1. Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus.
Arrabal-Gómez C; Serrano-Castro P; Sánchez-Pérez JA; Garcia-Casares N; Fuxe K; Borroto-Escuela D; Narváez M
Expert Opin Ther Targets; 2024 Apr; 28(4):309-322. PubMed ID: 38626283
[TBL] [Abstract][Full Text] [Related]
2. Galanin acts as a trophic factor to the central and peripheral nervous systems.
Hobson SA; Bacon A; Elliot-Hunt CR; Holmes FE; Kerr NC; Pope R; Vanderplank P; Wynick D
Cell Mol Life Sci; 2008 Jun; 65(12):1806-12. PubMed ID: 18500646
[TBL] [Abstract][Full Text] [Related]
3. Galanin, galanin receptor subtypes and depression-like behaviour.
Kuteeva E; Hökfelt T; Wardi T; Ogren SO
Cell Mol Life Sci; 2008 Jun; 65(12):1854-63. PubMed ID: 18500640
[TBL] [Abstract][Full Text] [Related]
4. Galanin and neuropeptide Y interactions elicit antidepressant activity linked to neuronal precursor cells of the dentate gyrus in the ventral hippocampus.
Borroto-Escuela DO; Pita-Rodriguez M; Fores-Pons R; Barbancho MA; Fuxe K; Narváez M
J Cell Physiol; 2021 May; 236(5):3565-3578. PubMed ID: 33044017
[TBL] [Abstract][Full Text] [Related]
5. GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant-like effects involving BDNF actions.
Alvarez-Contino JE; Díaz-Sánchez E; Mirchandani-Duque M; Sánchez-Pérez JA; Barbancho MA; López-Salas A; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
J Cell Physiol; 2023 Feb; 238(2):459-474. PubMed ID: 36599082
[TBL] [Abstract][Full Text] [Related]
6. Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder.
Borroto-Escuela D; Serrano-Castro P; Sánchez-Pérez JA; Barbancho-Fernández MA; Fuxe K; Narváez M
Expert Opin Ther Targets; 2024 Apr; 28(4):295-308. PubMed ID: 38622072
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions.
Sánchez-Varo R; López-Salas A; Beltran-Casanueva R; Díaz-Sánchez E; Alvarez-Contino JE; Barbancho-Fernández MA; Serrano-Castro P; Fuxe K; Borroto-Escuela DO; García-Casares N; Narváez M
Behav Brain Funct; 2024 Mar; 20(1):6. PubMed ID: 38549164
[TBL] [Abstract][Full Text] [Related]
8. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects.
Narváez M; Borroto-Escuela DO; Millón C; Gago B; Flores-Burgess A; Santín L; Fuxe K; Narváez JA; Díaz-Cabiale Z
Brain Struct Funct; 2016 Nov; 221(8):4129-4139. PubMed ID: 26666529
[TBL] [Abstract][Full Text] [Related]
9. Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus.
Beltran-Casanueva R; Hernández-García A; Serrano-Castro PJ; Sánchez-Pérez JA; Barbancho-Fernández MA; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
FASEB J; 2024 Apr; 38(7):e23595. PubMed ID: 38572811
[TBL] [Abstract][Full Text] [Related]
10. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
Ogren SO; Kuteeva E; Hökfelt T; Kehr J
CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides and hippocampal neurogenesis.
Zaben MJ; Gray WP
Neuropeptides; 2013 Dec; 47(6):431-8. PubMed ID: 24215800
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
